论文部分内容阅读
目的分析肝脏增强CT与肝脏MRI诊断肝癌的准确率。方法 64例肝癌患者,均予肝脏增强CT和肝脏MRI检查,并将其结果分别设为对照组与研究组,比较两组诊断准确率。结果研究组诊断准确率为95.31%高于对照组的84.38%(P<0.05);研究组诊断肿瘤直径≤3 cm准确率为92.31%高于对照组的66.67%(P<0.05)。研究组诊断肿瘤直径>3 cm准确率与对照组比较差异无统计学意义(P>0.05)。研究组合计检出率高于对照组(P<0.05)。结论与肝脏增强CT相比,肝脏MRI应用于肝癌的诊断准确率更高,尤其是对直径≤3 cm肿瘤,值得临床推广应用。
Objective To analyze the accuracy of liver enhanced CT and liver MRI in the diagnosis of liver cancer. Methods Sixty-four patients with hepatocellular carcinoma were enrolled in liver enhanced CT and liver MRI examinations, and the results were set as the control group and the study group respectively. The diagnostic accuracy of the two groups was compared. Results The diagnostic accuracy of the study group was 95.31%, which was significantly higher than that of the control group (84.38%, P <0.05). The diagnostic accuracy of the study group was 92.31% with the diameter of ≤ 3 cm, 66.67% (P <0.05) higher than that of the control group. The diagnostic accuracy of tumor diameter> 3 cm in study group was not significantly different from that in control group (P> 0.05). The detection rate of the study group was higher than that of the control group (P <0.05). Conclusion Compared with liver enhanced CT, the diagnostic accuracy of liver MRI for liver cancer is higher, especially for tumors with diameter ≤3 cm, which is worthy of clinical application.